Cargando…

The Mycobacterium tuberculosis CRISPR-Associated Cas1 Involves Persistence and Tolerance to Anti-Tubercular Drugs

Tuberculosis remains one of the leading causes of death worldwide. Even if new antitubercular drugs are currently being developed, the rapid emergence and spread of drug-resistant strain remain a severe challenge. The CRISPR associated proteins 1 (Cas1), a most conserved endonuclease which is respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Jiawei, Lu, Nan, Li, Zhiying, Wu, Xuanyan, Jiang, Tao, Xu, Li, Yang, Chun, Guo, Shuliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6466960/ https://www.ncbi.nlm.nih.gov/pubmed/31061828 http://dx.doi.org/10.1155/2019/7861695

Ejemplares similares

Regulation of CRISPR-Associated Genes by Rv1776c (CasR) in Mycobacterium tuberculosis
por: Wei, Wenping, et al.
Publicado: (2023)

How Mycobacterium tuberculosis drug resistance has shaped anti-tubercular drug discovery
por: Bhagwat, Amala, et al.
Publicado: (2022)

A new method for the detection of Mycobacterium tuberculosis based on the CRISPR/Cas system
por: Zhang, Xiaoyu, et al.
Publicado: (2023)

First-Line Anti-Tubercular Drug Resistance of Mycobacterium tuberculosis in IRAN: A Systematic Review
por: Pourakbari, Babak, et al.
Publicado: (2016)

The Involvement of Mycobacterium Type III-A CRISPR-Cas System in Oxidative Stress
por: Yang, Fan, et al.
Publicado: (2021)

Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids
por: Pawar, Alka, et al.
Publicado: (2020)

Mycobacterium tuberculosis and non-tubercular mycobacterium infection in women with unexplained infertility from eastern India
por: Chatterjee, Tridip, et al.
Publicado: (2018)

Multifaceted remodeling by vitamin C boosts sensitivity of Mycobacterium tuberculosis subpopulations to combination treatment by anti-tubercular drugs
por: Sikri, Kriti, et al.
Publicado: (2018)

The anti-tubercular activity of Melia azedarach L. and Lobelia chinensis Lour. and their potential as effective anti-Mycobacterium tuberculosis candidate agents
por: Choi, Won Hyung, et al.
Publicado: (2016)

CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy
por: Chen, Shuliang, et al.
Publicado: (2018)

Characterization of the MurT/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target
por: Maitra, Arundhati, et al.
Publicado: (2021)

Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis
por: Abdelrahman, Mohamed A., et al.
Publicado: (2022)

Tolerating the Unwelcome Guest; How the Host Withstands Persistent Mycobacterium tuberculosis
por: Olive, Andrew J., et al.
Publicado: (2018)

Multifocal Tubercular Osteomyelitis with Tubercular Breast Abscess: An Atypical Presentation of Tuberculosis
por: Bar, Mita, et al.
Publicado: (2015)

Development and preliminary assessment of a CRISPR–Cas12a-based multiplex detection of Mycobacterium tuberculosis complex
por: Xiao, Jing, et al.
Publicado: (2023)

Discovery of pyrimidine-tethered benzothiazole derivatives as novel anti-tubercular agents towards multi- and extensively drug resistant Mycobacterium tuberculosis
por: Hemeda, Loah R., et al.
Publicado: (2023)

The future of CRISPR in Mycobacterium tuberculosis infection
por: Zein-Eddine, Rima, et al.
Publicado: (2023)

The Role of the Novel Exopolyphosphatase MT0516 in Mycobacterium tuberculosis Drug Tolerance and Persistence
por: Thayil, Seema M., et al.
Publicado: (2011)

Tolerance and Persistence to Drugs: A Main Challenge in the Fight Against Mycobacterium tuberculosis
por: Boldrin, Francesca, et al.
Publicado: (2020)

CRISPR/Cas9: A Powerful Strategy to Improve CAR-T Cell Persistence
por: Wei, Wei, et al.
Publicado: (2023)

Anti‐CRISPRs: The natural inhibitors for CRISPR‐Cas systems
por: Zhang, Fei, et al.
Publicado: (2019)

A CRISPR-Cas12a-based platform for ultrasensitive rapid highly specific detection of Mycobacterium tuberculosis in clinical application
por: Jia, Nan, et al.
Publicado: (2023)

Insights into the molecular determinants involved in Mycobacterium tuberculosis persistence and their therapeutic implications
por: Joshi, Hemant, et al.
Publicado: (2021)

Estradiol inhibits autophagy of Mycobacterium tuberculosis-infected 16HBE cells and controls the proliferation of intracellular Mycobacterium tuberculosis
por: Gan, Yiling, et al.
Publicado: (2022)

Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimens
por: Ren, Weicong, et al.
Publicado: (2023)

Pyloric Tuberculosis and Tubercular Abscess of Stomach
Publicado: (1914)

Anti-CRISPR Phages Cooperate to Overcome CRISPR-Cas Immunity
por: Landsberger, Mariann, et al.
Publicado: (2018)

Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy
por: Xiao, Qiaoqiao, et al.
Publicado: (2019)

Disease extent and anti‐tubercular treatment response correlates with Mycobacterium tuberculosis‐specific CD4 T‐cell phenotype regardless of HIV‐1 status
por: Riou, Catherine, et al.
Publicado: (2020)

Lineage-Specific Proteomic Signatures in the Mycobacterium tuberculosis Complex Reveal Differential Abundance of Proteins Involved in Virulence, DNA Repair, CRISPR-Cas, Bioenergetics and Lipid Metabolism
por: Yimer, Solomon Abebe, et al.
Publicado: (2020)

High Persister Mutants in Mycobacterium tuberculosis
por: Torrey, Heather L., et al.
Publicado: (2016)

Development of CRISPR/Cas12b-Based Multiple Cross Displacement Amplification Technique for the Detection of Mycobacterium tuberculosis Complex in Clinical Settings
por: Yang, Xinggui, et al.
Publicado: (2023)

Adjunct therapy of Ayurvedic medicine with anti tubercular drugs on the therapeutic management of pulmonary tuberculosis
por: Debnath, P. K., et al.
Publicado: (2012)

Culturomics Discloses Anti-Tubercular Enterococci Exclusive of Pulmonary Tuberculosis: A Preliminary Report
por: Fellag, Mustapha, et al.
Publicado: (2020)

Nanocarrier-Based Approaches for the Efficient Delivery of Anti-Tubercular Drugs and Vaccines for Management of Tuberculosis
por: Rajput, Amarjitsing, et al.
Publicado: (2021)

Extreme Drug Tolerance of Mycobacterium abscessus “Persisters”
por: Yam, Yee-Kuen, et al.
Publicado: (2020)

CRISPR Interference of Adenylate Cyclases from Mycobacterium tuberculosis
por: Nadolinskaia, N. I., et al.
Publicado: (2021)

Paradoxical response to anti-tubercular treatment
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Unfamiliar Manifestations of Anti-tubercular Therapy
por: Aggarwal, Ramesh, et al.
Publicado: (2014)

CRISPR/Cas genome editing improves abiotic and biotic stress tolerance of crops
por: Li, Yangyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m28thq60hgla7lqnhmmrpvskie